• <font id="bhr3f"><span id="bhr3f"><delect id="bhr3f"></delect></span></font>


    November 2, 2021

    Antiva Biosciences Closes $31 Million Series D Equity Financing Read more

    April 21, 2021

    Antiva Biosciences Appoints Clifford Samuel to Board of Directors Read more

    November 9, 2018

    Antiva’s Gail Maderis Finds Inspiration in Today’s Biotech Innovation Read article (BioSpace)

    November 8, 2018

    San Francisco Business Times Names Gail Maderis One of 2018’s Most Admired CEOs Read article (SF Business Times)

    August 16, 2018

    A Women’s Health Startup Tried to Drum Up Interest for a Much-Needed Drug. Many Men Didn’t Get It Read article (STAT)

    July 10, 2018

    Antiva Biosciences Closes $15 Million Series C-1 Financing Read more

    March 28, 2017

    Antiva Biosciences Closes $22 Million Series C Financing Read more

    August 6, 2015

    Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections Read more

    August 6, 2015

    With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV Read article (Xconomy)

    August 6, 2015

    Why a longtime biotech exec shunned retirement for a 'breakthrough' Read article (SF Business Journal)